heptelidic acid has been researched along with 3-methyladenine in 1 studies
| Studies (heptelidic acid) | Trials (heptelidic acid) | Recent Studies (post-2010) (heptelidic acid) | Studies (3-methyladenine) | Trials (3-methyladenine) | Recent Studies (post-2010) (3-methyladenine) |
|---|---|---|---|---|---|
| 34 | 0 | 15 | 1,255 | 1 | 904 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gong, F; Jiang, Y; Liao, H; Liu, J; Peng, X; Wang, M; Xiao, G; Yu, M; Zhang, S | 1 |
1 other study(ies) available for heptelidic acid and 3-methyladenine
| Article | Year |
|---|---|
Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Deoxyglucose; Down-Regulation; Drug Resistance, Neoplasm; Female; Glycolysis; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Microtubule-Associated Proteins; Paclitaxel; RNA Interference; Sesquiterpenes; Signal Transduction; Ubiquitin-Activating Enzymes; Up-Regulation; Uterine Cervical Neoplasms | 2014 |